AMRX Total Non-Current Liabilities
Amneal Pharmaceuticals Inc Class A · Total Non-Current Liabilities
AMRX Total Non-Current Liabilities
Latest reported$2.79Bperiod ending
AMRX FY Total Non-Current Liabilities ($951.62M → $2.79B)
Annual total non-current liabilities
High-resolution chart · PNG
AMRX total non-current liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 2,790,684,000 | |
| 2,416,212,000 | |
| 2,564,670,000 | |
| 2,837,613,000 | |
| 2,895,448,000 | |
| 2,972,395,000 | |
| 2,768,696,000 | |
| 2,902,523,000 | |
| 1,420,588,000 | |
| 1,159,566,000 | |
| 951,621,000 |